MedTrace Logo

Effect of Spirulina Compared to Amlodipine on Cardiac Iron Overload in Children With Beta Thalassemia

NCT02671695 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-07-12

No results posted yet for this study

Summary

the aim of this study is to evaluate the effect of Spirulina compared to Amlodipine on cardiac iron overload and cardiac functions in multi-transfused children with beta thalassemia major

Conditions

  • Beta Thalassemia Major

Interventions

DRUG

Spirulina

Spirulina capsules (500 mg) in a dose of 250 mg/kg/day orally for 3 months

DRUG

Amlodipine

Amlodipine in a dose of 5 mg/day orally for 3 months

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • Sahar M El-Haggar, MD · assisstant professor of clinical pharmacy- Faculty of Pharmacy- Tanta University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2018-04-30
Completion
2018-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02671695 on ClinicalTrials.gov